Hydroxyurea,
Showing 1 - 25 of 441
Thalassemia, Beta Trial in Karachi (Hydroxyurea and Thalidomide)
Completed
- Thalassemia, Beta
- Hydroxyurea and Thalidomide
-
Karachi, Sindh, PakistanChildren's Hospital Karachi
Nov 23, 2023
Sickle Cell Anemia in Children, Sickle Cell Disease Trial in Luanda (Hydroxyurea)
Not yet recruiting
- Sickle Cell Anemia in Children
- Sickle Cell Disease
-
Luanda, AngolaHospital Geral dos Cajueiros
Jan 26, 2023
Sickle-Cell Anaemia Trial in Kinshasa (Hydroxyurea)
Completed
- Sickle-Cell Anaemia
-
Kinshasa, Congo, The Democratic Republic of theUniversity of Kinshasa
Dec 27, 2022
Polycythemia Vera Trial (Givinostat Hydrochloride, Hydroxy Urea)
Not yet recruiting
- Polycythemia Vera
- Givinostat Hydrochloride
- Hydroxy Urea
- (no location specified)
Oct 19, 2023
Enablers and Barriers to Hydroxyurea Use for Sickle Cell Disease
Recruiting
- Sickle Cell Disease
- questionnaires (surveys)
-
Kingston, Saint Andrew, JamaicaSickle Cell Unit - Caribbean Institute for Health Research
Jun 16, 2023
Polycythemia Vera Trial in Tianjin (Ruxolitinib, Pegylated interferon a-2b)
Recruiting
- Polycythemia Vera
- Ruxolitinib
- Pegylated interferon α-2b
-
Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
May 19, 2023
Sickle Cell Disease Trial in Jinja (Hydroxyurea)
Recruiting
- Sickle Cell Disease
-
Jinja, UgandaJinja Regional Referral Hospital (JRRH), Department of Paediatri
Dec 14, 2022
Essential Thrombocythemia Trial (Bomedemstat, Anagrelide, Busulfan)
Not yet recruiting
- Essential Thrombocythemia
- Bomedemstat
- +4 more
- (no location specified)
Oct 6, 2023
Anemia, Sickle Cell, Sickle Cell Disease Trial in Pittsburgh, Lagos (Hydroxyurea, Epoetin Alfa)
Not yet recruiting
- Anemia, Sickle Cell
- Sickle Cell Disease
- Hydroxyurea
- Epoetin Alfa
-
Pittsburgh, Pennsylvania
- +1 more
Aug 4, 2022
Sickle Cell Disease, Thalassemia Trial in Memphis (Hydroxyurea, Hydroxyurea Oral Capsule)
Terminated
- Sickle Cell Disease
- Thalassemia
- Hydroxyurea
- Hydroxyurea Oral Capsule
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Feb 18, 2022
Sickle Cell Anemia in Children Trial in Kampala (Hydroxyurea)
Active, not recruiting
- Sickle Cell Anemia in Children
-
Kampala, UgandaGlobal Health Uganda
May 11, 2022
Myelodysplastic/Myeloproliferative Tumor With Ring Sideroblasts and Thrombocytosis, Myelodysplastic/Myeloproliferative Tumor,
Recruiting
- Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis
- Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
- Hydroxyurea
- Luspatercept
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 6, 2023
Sickle Cell Disease, Sickle Cell Anemia, Stroke Trial in Kano (Moderate Dose Hydroxyurea, Low Dose Hydroxyurea)
Completed
- Sickle Cell Disease
- +2 more
- Moderate Dose Hydroxyurea
- Low Dose Hydroxyurea
-
Kano, Nigeria
- +1 more
Jan 16, 2022
Adding Azathioprine/Hydroxyurea Preconditioning to
Recruiting
- Sickle Cell Disease
- Preconditioning with azathiprine and hydroxyurea (3 months)
-
Amsterdam, NetherlandsAmsterdam Medical Centre
Feb 9, 2022
Sickle Cell Disease Trial in Worldwide (Hydroxyurea)
Active, not recruiting
- Sickle Cell Disease
-
Luanda, Angola
- +3 more
Dec 13, 2021
Sickle Cell Disease, Hydroxyurea Failure, Hydroxyurea Intolerance Trial in Nashville (CTX001)
Recruiting
- Sickle Cell Disease
- +4 more
- CTX001
-
Philadelphia, Pennsylvania
- +3 more
Jan 24, 2023
Ruxolitinib for Polycythemia Vera in Patients Resistant to or
Completed
- Polycythemia Vera (PV)
- Ruxolitinib
-
East Hanover, New JerseyNovartis Investigative Site
Jun 29, 2022
Sickle Cell Disease Trial in Washington (Hydroxyurea)
Completed
- Sickle Cell Disease
-
Washington, District of ColumbiaChildren's National Health System
Oct 19, 2021
Sickle Cell Disease Trial in United States (InCharge Health mobile application, HU Toolbox mobile application)
Completed
- Sickle Cell Disease
- InCharge Health mobile application
- HU Toolbox mobile application
-
Augusta, Georgia
- +6 more
Sep 26, 2022
Anemia, Sickle Cell Trial in Cincinnati (Hydroxyurea)
Recruiting
- Anemia, Sickle Cell
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Dec 7, 2021
Thalassemia, Beta Trial in Karachi (hydroxyurea and thalidomide)
Completed
- Thalassemia, Beta
- hydroxyurea and thalidomide
-
Karachi, Sindh, PakistanChildren's Hospital Karachi
Nov 11, 2021
Sickle Cell Anemia in Children Trial in Cincinnati, Mwanza (Hydroxyurea, Elevated Arm TCD Examination, Normal Arm TCD
Active, not recruiting
- Sickle Cell Anemia in Children
- Hydroxyurea
- +2 more
-
Cincinnati, Ohio
- +1 more
Dec 7, 2021